Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The primary objective of the study aims to compare the biodiversity of intestinal microbiota between spondylarthritis (SPA) or rheumatoid arthritis (RA) patients and healthy volunteers, by microbiota DNA sequencing in order to further and respond the prior results, which suggested that there is a specific dysbiosis for each of the 2 diseases. A comparative analysis will allow to identify the biomarkers of the specific bacteria.
Eligibility criteria
Qualifiers
Patient ⩾ 18 years;
Diagnosed as spondyloarthritis (SpA) according ASAS classification, or rheumatoid polyarthritis according ACR/EULAR;
Affiliated to a social security scheme;
Have signed the written informed consent form.
Disqualifiers
Patients unable to understand the proposed study and/or sign a informed consent form;
Pregnant women or breast feeding women;
Patient ⩾ 18 years;
Patients under guardianship or curatorship;
Trial design
Treatments tested in this trial
- Faecal sampling
- Blood sampling
Treatment groups
400 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov